STOCK TITAN
  1. Home
  2. Sec-filings
  3. AIP
  4. [Form 4] Arteris, Inc. Insider Trading Activity

Arteris (AIP) CFO exercises 3,125 options, sells 10,631 common shares

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Arteris, Inc. VP and CFO Nicholas B. Hawkins reported an option exercise and share sales. On August 13, 2026 he exercised 3,125 Non-Qualified Stock Options at an exercise price of $9.28 per share, receiving 3,125 shares of common stock, and leaving 31,250 options outstanding from this grant. The options vest in 16 equal quarterly installments beginning April 1, 2025. On August 12–13, 2026 he sold a total of 10,631 shares of common stock in transactions at prices around $28.26–$29.00 per share, including a weighted average sale price of $28.2646, with all holdings reported as direct ownership.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Hawkins Nicholas B.
Role VP and Chief Financial Officer
Sold 10,631 shs ($301K)
Approx. gross sale proceeds $301K
Approx. exercise cost $29K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) F2 3,125 $0.00 $0.00
Exercise Common Stock 3,125 $9.28 $29K
Sale Common Stock F1 10,431 $28.2646 $295K
Sale Common Stock 200 $29.00 $6K
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 31,250 shares (Direct); Common Stock — 95,666 shares (Direct)
Footnotes (2)
  1. F1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.26 to $28.38 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2. Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.
Options exercised 3,125 shares Non-Qualified Stock Options exercised on August 13, 2026
Option exercise price $9.28 per share Exercise price of Non-Qualified Stock Options
Options remaining from grant 31,250 options Non-Qualified Stock Options following the reported exercise
Shares sold 10,631 shares Common stock sales on August 12–13, 2026
Weighted average sale price $28.2646 per share Weighted average price for 10,431-share sale on August 13, 2026
Additional sale price $29.00 per share Price for 200-share sale on August 12, 2026
Option vesting schedule 16 installments Vesting in 16 equal quarterly installments beginning April 1, 2025
Option expiration date February 20, 2035 Expiration date of the Non-Qualified Stock Options
Non-Qualified Stock Option financial
"Non-qualified stock options, vesting in 16 equal quarterly installments"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
vesting in 16 equal quarterly installments financial
"Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each"

FAQ

What did Arteris (AIP) CFO Nicholas B. Hawkins do in this Form 4 filing?
Nicholas B. Hawkins exercised 3,125 stock options at $9.28 per share and sold 10,631 common shares on August 12–13, 2026, all reported as directly held.

How many Arteris (AIP) options did the CFO exercise and at what price?
He exercised 3,125 Non-Qualified Stock Options on August 13, 2026 at an exercise price of $9.28 per share, receiving the same number of Arteris common shares.

How many Arteris (AIP) shares did the CFO sell and at what prices?
He sold 10,631 common shares of Arteris, Inc., including 10,431 shares at a $28.2646 weighted average price and 200 shares at $29.00, over August 12–13, 2026.

What Arteris (AIP) option holdings remain after the CFO’s transactions?
Following the reported option exercise, Hawkins held 31,250 Non-Qualified Stock Options from this grant, which vest in 16 equal quarterly installments beginning April 1, 2025.

Are the Arteris (AIP) CFO’s reported holdings in this Form 4 direct or indirect?
All reported securities in this Form 4, including the options and common stock, are listed with direct ownership, meaning they are held directly by Nicholas B. Hawkins.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hawkins Nicholas B.
(Last)(First)(Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300
(Street)
CAMPBELL CALIFORNIA 95008
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP and Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/12/2026S200D$29102,972D
Common Stock08/13/2026M3,125A$9.28106,097D
Common Stock08/13/2026S10,431D$28.2646(1)95,666D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy)$9.2808/13/2026M3,125 (2)02/20/2035Common Stock3,125$0.0031,250D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.26 to $28.38 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for Hawkins Nicholas B.08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR